Xiaoluan Yan
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 28
- Colorectal Cancer Treatments and Studies 21
- Pancreatic and Hepatic Oncology Research 6
- Inflammatory Biomarkers in Disease Prognosis 3
- Hepatology 20
- Hepatocellular Carcinoma Treatment and Prognosis 20
- Co-authors
- Baocai Xing (21 shared papers)Kun Wang (19 shared papers)Quan Bao (15 shared papers)Da Xu (9 shared papers)Kemin Jin (14 shared papers)Yi Sun (6 shared papers)Hongwei Wang (5 shared papers)Bao-Cai Xing (4 shared papers)
- Journals
- European Journal of Surgical Oncology (4 papers)Annals of Oncology (2 papers)Frontiers in Oncology (2 papers)Hepatology International (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaEthiopiaUnited Kingdom
In The Last Decade
Xiaoluan Yan
31 papers receiving 363 citations
Xiaoluan Yan's Hit Papers
Peers
Comparison fields: 5 of 55
- Hepatology 215
- Oncology 238
- Cancer Research 48
- Surgery 111
- Pulmonary and Respiratory Medicine 75
Countries citing papers authored by Xiaoluan Yan
This map shows the geographic impact of Xiaoluan Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoluan Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoluan Yan more than expected).
Fields of papers citing papers by Xiaoluan Yan
This network shows the impact of papers produced by Xiaoluan Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoluan Yan. The network helps show where Xiaoluan Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoluan Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | [Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer-a multifactorial model of 191 patients]. | 2014 | 65 |
| 2 | 2018 | 36 | |
| 3 | 2022 | 31 | |
| 4 | 2017 | 31 | |
| 5 | 2018 | 30 | |
| 6 | 2019 | 19 | |
| 7 | The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial Hit paper breakdown → | 2025 | 17 |
| 8 | 2017 | 15 | |
| 9 | 2023 | 14 | |
| 10 | 2016 | 12 | |
| 11 | 2021 | 10 | |
| 12 | 2020 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2014 | 8 | |
| 15 | 2021 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2023 | 6 | |
| 18 | 2020 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2024 | 4 |
About Xiaoluan Yan
Xiaoluan Yan is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 33 papers that have together received 363 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Gastric Cancer Management and Outcomes (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Lung Cancer Treatments and Mutations (4 papers), Genetic factors in colorectal cancer (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). The work is most often cited by research in Hepatology (215 citations), Oncology (238 citations), Cancer Research (48 citations), Surgery (111 citations) and Pulmonary and Respiratory Medicine (75 citations). Xiaoluan Yan has collaborated with scholars based in China, Ethiopia and United Kingdom. Frequent co-authors include Baocai Xing, Kun Wang, Quan Bao, Da Xu, Kemin Jin, Yi Sun, Hongwei Wang, Bao-Cai Xing, Qinglong Jiang and Graeme J. Poston. Their work appears in journals such as European Journal of Surgical Oncology, Annals of Oncology, Frontiers in Oncology, Hepatology International and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.